Reuters logo
a month ago
BRIEF-Rasrx receives orphan drug designation for its compound RASRx1902 from FDA
June 15, 2017 / 7:00 PM / a month ago

BRIEF-Rasrx receives orphan drug designation for its compound RASRx1902 from FDA

1 Min Read

June 15 (Reuters) - Rasrx :

* Rasrx receives orphan drug designation from FDA

* U.S. FDA has granted an orphan drug designation for its compound RASRx1902 for treatment of duchenne muscular dystrophy Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below